Drug discovery has focused on ~2% of the genome. We're going after the rest.
Proud to join the @nvidia Inception program as we build our AI discovery engine for the dark proteome with Google for Startups.
#NVIDIAInception#DarkProteome#AI
NonExomics is featured in @NatureBiotech’s September survey of the dark proteome, among the companies turning the dark genome into new drug targets.
~3,000 novel dark antigens across 1,365 human diseases, prioritized and experimentally validated.
nature.com/articles/s41587-0…
Big news: NonExomics has joined the Google for Startups Cloud Program
More compute = more of the genome brought into the light.
Onward to mapping the dark proteome.
#biotech#drugdiscovery#GoogleCloud#darkproteome
Honored to be featured by @saplabsindia. Incredibly grateful to @gangadharansind , @anzieee & @prakr_tea.✨
Aarini, an e-book compilation of how our unique narratives/adventures weave into underlying themes of empowerment & resilience.
Also, thanks for the support @NonExomics!
Proud to announce that our COO @chauhan_rcs will be speaking at the #WomenInBiotech event organized by @BIA_UK on 9th March in Welcome Genome Campus, UK to celebrate International Women's Day.
bioindustry.org/event-listin…
We are grateful to Cambridgeshire & Peterborough Combined Authority for supporting our science and company through investment #science#grateful#darkgenome#nORFs#cambridge@CambsPboroCA. We are also grateful to the team members who worked with us through the process.
👋 Meet @NonExomics, a #techbio company that mines novel disease-associated proteins from the entire human genome! They have used their technology to identify around 250,000 proteins that haven't been discovered before 👀
Read the innovator spotlight 👇
ow.ly/FpVH50LIjuF
This morning at the Illumina Genomics Forum, we unveiled our fastest, most cost-efficient sequencing machine yet – the NovaSeq X series. This technology will slash the cost to $200 per human genome and provide a readout at twice the speed. @WIRED feature: wired.com/story/the-era-of-f…